In recent years, the role for multiparametric MRI in prostate cancer detection and management has expanded. Ongoing research shows that potential for multiparametric MRI to help reduce instances of overtreatment and understaging. One barrier to mainstream implementation has been a lack of standardization in the interpretation and reporting of multiparametric MRI exams. However, the Prostate Imaging Reporting and Data System (PI-RADS) helps to solve that problem. […]
The American Cancer Society estimates that more than 220,000 men will be diagnosed with prostate cancer in 2015. Around 1 in 7 men will be diagnosed during their lifetimes. This September, the RadNet Prostate MRI program encourages men to learn more about prostate cancer and their prostate cancer imaging options. […]
By Joshua I. Gottlieb, OMSII; Roy Gottlieb, D.O. FSCCT
The CTA study performed for pre-pulmonary ablation therapy revealed an enlarged anomalous right superior pulmonary vein draining into the superior vena cava as demonstrated on the coronal, 3D image (figure 1), and axial (figure 2) images. This anomaly is associated with a sinus venosus type atrial septal defect (SVASD) well demonstrated on this reconstructed four-chamber view of the heart (figure 3). The sinus venosus atrial septal defect (SVASD) and the partial anomalous pulmonary venous return (PAPVR) contribute to a left-right […]
In recent years, recommendations for prostate cancer screening have been caught amidst growing controversy. The utility of prostate-specific antigen (PSA) testing, the most prominent front-line screening exam for prostate cancer has been heavily critiqued. Meanwhile, numerous men present with incurable late-stage prostate cancer while men with low-risk, indolent disease receive treatment that offers little benefit in terms of health outcomes. Prostate cancer patients and their physicians have long sought an alternative to the current standard of care in prostate cancer detection and diagnosis. Multiparametric MRI is an emerging technology that could be added to PSA-based prostate cancer screening to […]
Annual mammogram screening beginning at age 40 saves lives. U.S. Preventive Services Task Force (USPSTF) recommends less frequent screening at a later age, not because screening will not save lives, but because it will not save sufficient numbers of lives when started before age 50.
The guidelines are based on outdated, blemished data and do not evaluate cost-effectiveness or any other benefits of early detection. In fact, USPSTF states, “Screening mammography in women ages 40 to 49 years may reduce the risk of dying of breast cancer, but the number of deaths averted is much smaller than in older women and […]